BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29
• 30

• Policy

  Daiichi Sankyo, Inc. Release: New Study Demonstrates Colesevelam HCl Lowers Both A1C and LDL Cholesterol in Patients With Uncontrolled Type 2 Diabetes Mellitus on Metformin-Based Regimen

  June 25, 2007

   · 

  10 min read
• BioForest

  FEI Company’s new Phenom(TM) Bridges the Gap Between Optical and Scanning Electron Microscopy

  June 25, 2007

   · 

  4 min read
• Drug Development

  Neurogen Corporation Announces Positive Results for Proprietary Insomnia Drug in Two Chronic Insomnia Clinical Trials

  June 25, 2007

   · 

  11 min read
• Business

  Research Dynamics Consulting Group, Ltd. Awarded Multicenter Clinical Study Using a Novel Gene Therapy

  June 25, 2007

   · 

  1 min read
• Business

  BioStorage Technologies, Inc. Hires James M. Saponaro as Executive Vice President

  June 25, 2007

   · 

  3 min read
• Sussex Research Introduces Unique Sialic Acid-like Pseudaminic Acid Products for Research into Infectious Diseases

  June 25, 2007

   · 

  2 min read
• Business

  MicuRx Pharmaceuticals Completes $10 Million Series A Financing to Fund Discovery and Development of Next-Generation Antibiotics

  June 25, 2007

   · 

  2 min read
• Drug Development

  Bristol-Myers Squibb (Jobs) and AstraZeneca PLC (Jobs) Release: First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes

  June 25, 2007

   · 

  8 min read
• BioMidwest

  Orexigen Therapeutics, Inc. Reports Contrave(TM) Has Positive Effect on Visceral Fat and Insulin Resistance, Factors Believed to Contribute to the Risk of Heart Disease and Type II Diabetes

  June 25, 2007

   · 

  5 min read
• BioMidwest

  American Diabetes Association Conference Presentations Highlight Isis Pharmaceuticals, Inc.'s Metabolic Disease Program Research Activities

  June 25, 2007

   · 

  15 min read